83027-0118 NDC - CELLULAR OXYGENATOR (CACTUS GRANDIFLORUS, ASCORBICUM ACIDUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, THIAMINUM HYDROCHLORICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, RIBOFLAVINUM, MAGNESIA PHOSPHORICA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, ANTHRACHINONUM, COENZYME A, NADIDUM, NAJA TRIPUDIANS, UBIDECARENONUM (COQ10))

Drug Information

  • Product NDC: 83027-0118
  • Proprietary Name: Cellular Oxygenator
  • Non Proprietary Name: Cactus Grandiflorus, Ascorbicum Acidum, Nicotinamidum, Pyridoxinum Hydrochloricum, Thiaminum Hydrochloricum, Magnesium Gluconicum Dihydricum, Riboflavinum, Magnesia Phosphorica, Adenosinum Triphosphoricum Dinatrum, Alpha-Lipoicum Acidum, Anthrachinonum, Coenzyme A, Nadidum, Naja Tripudians, Ubidecarenonum (CoQ10)
  • Active Ingredient(s): 12 [hp_X]/mL ADENOSINE TRIPHOSPHATE DISODIUM; 12 [hp_X]/mL ALPHA LIPOIC ACID; 12 [hp_X]/mL ANTHRAQUINONE; 6 [hp_X]/mL ASCORBIC ACID; 12 [hp_X]/mL COENZYME A; 8 [hp_X]/mL MAGNESIUM GLUCONATE; 10 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; 12 [hp_X]/mL NADIDE; 12 [hp_X]/mL NAJA NAJA VENOM; 6 [hp_X]/mL NIACINAMIDE; 6 [hp_X]/mL PYRIDOXINE HYDROCHLORIDE; 8 [hp_X]/mL RIBOFLAVIN; 4 [hp_X]/mL SELENICEREUS GRANDIFLORUS STEM; 6 [hp_X]/mL THIAMINE HYDROCHLORIDE; 12 [hp_X]/mL UBIDECARENONE
  • Administration Route(s): ORAL
  • Dosage Form(s): SPRAY
  • Pharmacy Class(es): Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]; Vitamin C [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Nutritional Specialties, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:11/21/2023

Package Information

No. Package Code Package Description Billing Unit
183027-0118-160 mL in 1 BOTTLE, SPRAY (83027-0118-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC83027-0118The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMECellular OxygenatorThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECactus Grandiflorus, Ascorbicum Acidum, Nicotinamidum, Pyridoxinum Hydrochloricum, Thiaminum Hydrochloricum, Magnesium Gluconicum Dihydricum, Riboflavinum, Magnesia Phosphorica, Adenosinum Triphosphoricum Dinatrum, Alpha-Lipoicum Acidum, Anthrachinonum, Coenzyme A, Nadidum, Naja Tripudians, Ubidecarenonum (CoQ10)The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESPRAYThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE11/21/2023This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENutritional Specialties, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; ANTHRAQUINONE; ASCORBIC ACID; COENZYME A; MAGNESIUM GLUCONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NADIDE; NAJA NAJA VENOM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENICEREUS GRANDIFLORUS STEM; THIAMINE HYDROCHLORIDE; UBIDECARENONEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH12; 12; 12; 6; 12; 8; 10; 12; 12; 6; 6; 8; 4; 6; 12 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAnalogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 7/4/2025

Previous Code
Next Code